ANDERSEN GLOBAL FDA Approval ANDA 214455

ANDA 214455

ANDERSEN GLOBAL

FDA Drug Application

Application #214455

Application Sponsors

ANDA 214455ANDERSEN GLOBAL

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 1MG BASE/ML0NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATE

FDA Submissions

UNKNOWN; ORIG1AP2021-01-22STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

ANDERSEN GLOBAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214455
            [companyName] => ANDERSEN GLOBAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"NOREPINEPHRINE BITARTRATE","activeIngredients":"NOREPINEPHRINE BITARTRATE","strength":"EQ 1MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/22\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-01-22
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.